🇺🇸 FDA
Patent

US 8465917

Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells

granted A61PA61P35/00

Quick answer

US patent 8465917 (Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
Grant date
Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P35/00